Host response to Helicobacter pylori infection before initiation of the adaptive immune response
- PMID: 17919297
- DOI: 10.1111/j.1574-695X.2007.00338.x
Host response to Helicobacter pylori infection before initiation of the adaptive immune response
Abstract
Helicobacter pylori persistently colonizes the human stomach. In this study, immune responses to H. pylori that occur in the early stages of infection were investigated. Within the first 2 days after orogastric infection of mice with H. pylori, there was a transient infiltration of macrophages and neutrophils into the glandular stomach. By day 10 postinfection, the numbers of macrophages and neutrophils decreased to baseline levels. By 3 weeks postinfection, an adaptive immune response was detected, marked by gastric infiltration of T lymphocytes, macrophages, and neutrophils, as well as increased numbers of H. pylori-specific T cells, macrophages, and dendritic cells in paragastric lymph nodes. Neutrophil-attracting and macrophage-attracting chemokines were expressed at higher levels in the stomachs of H. pylori-infected mice than in the stomachs of uninfected mice. Increased expression of TNFalpha and IFNgamma (Th1-type inflammatory cytokines) and IL-17 (a Th17-type cytokine) was detected in the stomachs of H. pylori-infected mice, but increased expression of IL-4 (a Th2-type cytokine) was not detected. These data indicate that a transient gastric inflammatory response to H. pylori occurs within the first few days after infection, before the priming of T cells and initiation of an adaptive immune response. It is speculated that inappropriate waning of the innate immune response during early stages of infection may be a factor that contributes to H. pylori persistence.
Similar articles
-
Antigen-specific lymphocyte proliferation as a marker of immune response in guinea pigs with sustained Helicobacter pylori infection.Acta Biochim Pol. 2014;61(2):295-303. Epub 2014 Jun 13. Acta Biochim Pol. 2014. PMID: 24918491
-
Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice.Vaccine. 2012 Feb 21;30(9):1636-43. doi: 10.1016/j.vaccine.2011.12.111. Epub 2012 Jan 9. Vaccine. 2012. PMID: 22230589
-
Helicobacter pylori-induced Th17 responses modulate Th1 cell responses, benefit bacterial growth, and contribute to pathology in mice.J Immunol. 2010 May 1;184(9):5121-9. doi: 10.4049/jimmunol.0901115. Epub 2010 Mar 29. J Immunol. 2010. PMID: 20351183
-
Interplay between Helicobacter pylori and the immune system. Clinical implications.J Physiol Pharmacol. 2006 Sep;57 Suppl 3:15-27. J Physiol Pharmacol. 2006. PMID: 17033103 Review.
-
[Helicobacter pylori infection and phagocytosis].Mikrobiyol Bul. 2008 Jan;42(1):177-84. Mikrobiyol Bul. 2008. PMID: 18444577 Review. Turkish.
Cited by
-
Immune Biology and Persistence of Helicobacter pylori in Gastric Diseases.Curr Top Microbiol Immunol. 2023;444:83-115. doi: 10.1007/978-3-031-47331-9_4. Curr Top Microbiol Immunol. 2023. PMID: 38231216
-
Innate Immunity Crosstalk with Helicobacter pylori: Pattern Recognition Receptors and Cellular Responses.Int J Mol Sci. 2022 Jul 8;23(14):7561. doi: 10.3390/ijms23147561. Int J Mol Sci. 2022. PMID: 35886908 Free PMC article. Review.
-
Proteolytic Landscapes in Gastric Pathology and Cancerogenesis.Int J Mol Sci. 2022 Feb 22;23(5):2419. doi: 10.3390/ijms23052419. Int J Mol Sci. 2022. PMID: 35269560 Free PMC article. Review.
-
The TNF-Alpha Inducing Protein is Associated With Gastric Inflammation and Hyperplasia in a Murine Model of Helicobacter pylori Infection.Front Pharmacol. 2022 Feb 14;13:817237. doi: 10.3389/fphar.2022.817237. eCollection 2022. Front Pharmacol. 2022. PMID: 35237167 Free PMC article.
-
NF-κB in Gastric Cancer Development and Therapy.Biomedicines. 2021 Jul 23;9(8):870. doi: 10.3390/biomedicines9080870. Biomedicines. 2021. PMID: 34440074 Free PMC article. Review.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical